Treatment
Aripiprazole clinical trials
We’re tracking 8 recruiting studies that include Aripiprazole, each written for real people, not researchers, below.
Recruiting studies
- NCT07215884RecruitingPhase 1
Dopamine and movement in people who stutter
This study looks at how dopamine affects speech and movement in adults who stutter. It may help us understand why stuttering happens.
San Francisco, CaliforniaAges 18–65 - NCT07565428RecruitingPhase 3
Study of roluperidone for negative symptoms of schizophrenia
This trial tests a new medicine called roluperidone for people with schizophrenia who have ongoing negative symptoms (like low motivation or social withdrawal) but stable positive symptoms (like hallucinations). It aims to see if the drug helps with these symptoms and if it can reduce the chance of relapse compared to other medications.
Bellflower, CaliforniaAges 18–55 - NCT05814640RecruitingPhase 1/Phase 2
STAR-AD: Testing stepwise treatment for teen depression
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
Chongqing, ProvinceAges 13–18 - NCT06969755RecruitingPhase 4
Brain scans and genetics to guide early schizophrenia treatment
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
Birmingham, AlabamaAges 18–35 - NCT03423680RecruitingPhase 3
Aripiprazole added to mood stabilizers for bipolar depression
This trial tests whether adding aripiprazole (Abilify) to a mood stabilizer helps people with bipolar disorder who are currently in a major depressive episode. It may help improve depressive symptoms compared with the mood stabilizer alone.
SeoulAges 19–70 - NCT04539951RecruitingPhase 2
Trial for newly treated obsessive-compulsive disorder
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06581302Recruiting
Magnetic seizure therapy for psychotic disorders
This trial tests magnetic seizure therapy (MST) as a treatment for people with schizophrenia or other psychotic disorders. It aims to see if MST can help reduce symptoms like hallucinations or delusions.
Shanghai, Shanghai MunicipalityAges 18–55 - NCT07483294RecruitingPhase 4
Brain imaging study for first-episode psychosis treatment
This study uses brain scans to find markers that can predict how well antipsychotic medications work in people having their first episode of psychosis. It aims to help doctors choose the right treatment earlier.
Glen Oaks, New YorkAges 15–40
What Aripiprazole is being studied for
Conditions with recruiting Aripiprazole studies.
Common questions
- Are there clinical trials studying Aripiprazole?
- Yes. Clin2 currently lists 8 recruiting studies that include Aripiprazole, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Aripiprazole trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Aripiprazole an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Aripiprazole or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.